Senescent cells as a source of inflammatory factors for tumor progression

Cellular senescence, which is associated with aging, is a process by which cells enter a state of permanent cell cycle arrest, therefore constituting a potent tumor suppressive mechanism. Recent studies show that, despite the beneficial effects of cellular senescence, senescent cells can also exert harmful effects on the tissue microenvironment. The most significant of these effects is the acquisition of a senescent-associated secretory phenotype (SASP), which entails a striking increase in the secretion of pro-inflammatory cytokines. Here, we summarize our knowledge of the SASP and the impact it has on tissue microenvironments and ability to stimulate tumor progression.

[1]  D. Roeder,et al.  Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. , 1990, Science.

[2]  P. Hornsby,et al.  Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. , 2007, Cancer research.

[3]  H. Huttunen,et al.  Regulation of cell migration by amphoterin. , 2000, Journal of cell science.

[4]  N. Sharpless,et al.  Ink4a/Arf expression is a biomarker of aging. , 2004, The Journal of clinical investigation.

[5]  P. Fisher,et al.  Modulating T cell signals using CD3/CD28 Xcyte™ Dynabeads® allows for selective expansion or deletion of antigen-specific T cells , 2004 .

[6]  M. Feldmann,et al.  Cytokine expression in chronic inflammatory disease. , 1995, British medical bulletin.

[7]  M. Narita,et al.  SASP reflects senescence , 2009, EMBO reports.

[8]  F. Balkwill Cancer and the chemokine network , 2004, Nature Reviews Cancer.

[9]  J. Campisi,et al.  Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion , 2009, Nature Cell Biology.

[10]  Jonathan Melamed,et al.  Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence , 2008, Cell.

[11]  C. Baglioni,et al.  Expression of interleukin 1-inducible genes and production of interleukin 1 by aging human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[13]  K. Camphausen,et al.  Radiation therapy to a primary tumor accelerates metastatic growth in mice. , 2001, Cancer research.

[14]  D. Terrian,et al.  Senescence-associated exosome release from human prostate cancer cells. , 2008, Cancer research.

[15]  Judith Campisi,et al.  Cancer and ageing: rival demons? , 2003, Nature Reviews Cancer.

[16]  S. Lowe,et al.  Tumor suppression by Ink4a-Arf: progress and puzzles. , 2003, Current opinion in genetics & development.

[17]  Robert D. Cardiff,et al.  Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis , 2005, Cell.

[18]  S. Lowe,et al.  Senescence of Activated Stellate Cells Limits Liver Fibrosis , 2008, Cell.

[19]  P. Chiao,et al.  Identification of an autoregulatory feedback pathway involving interleukin-1alpha in induction of constitutive NF-kappaB activation in pancreatic cancer cells. , 2004, The Journal of biological chemistry.

[20]  J. Campisi,et al.  Secretion of Vascular Endothelial Growth Factor by Primary Human Fibroblasts at Senescence* , 2006, Journal of Biological Chemistry.

[21]  M. Serrano,et al.  The power and the promise of oncogene-induced senescence markers , 2006, Nature Reviews Cancer.

[22]  P. Claudio,et al.  Molecular basis of angiogenesis and cancer , 2003, Oncogene.

[23]  E. Abraham,et al.  HMGB1 Develops Enhanced Proinflammatory Activity by Binding to Cytokines1 , 2008, The Journal of Immunology.

[24]  C. Schmitt,et al.  Oncogene-induced senescence: putting the brakes on tumor development. , 2006, Cancer research.

[25]  W. Birchmeier,et al.  Met, metastasis, motility and more , 2003, Nature Reviews Molecular Cell Biology.

[26]  K. Ohuchida,et al.  Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. , 2004, Cancer research.

[27]  J. Bridger,et al.  Alterations to Nuclear Architecture and Genome Behavior in Senescent Cells , 2007, Annals of the New York Academy of Sciences.

[28]  N. Holbrook,et al.  Oxidants, oxidative stress and the biology of ageing , 2000, Nature.

[29]  J. Hiscott,et al.  Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop , 1993, Molecular and cellular biology.

[30]  A. Zlotnik,et al.  Chemokines: agents for the immunotherapy of cancer? , 2002, Nature Reviews Immunology.

[31]  M. Narita,et al.  Cellular senescence and chromatin organisation , 2007, British Journal of Cancer.

[32]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[33]  Kevin J. Tracey,et al.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.

[34]  P. Adams Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. , 2007, Gene.

[35]  I. Roninson,et al.  Tumor suppressor maspin is up-regulated during keratinocyte senescence, exerting a paracrine antiangiogenic activity. , 2004, Cancer research.

[36]  Judith Campisi,et al.  Cell surface-bound IL-1α is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network , 2009, Proceedings of the National Academy of Sciences.

[37]  G. Martin Genetic Modulation of Senescent Phenotypes in Homo sapiens , 2005, Cell.

[38]  J. Shay,et al.  Cellular senescence as a tumor-protection mechanism: the essential role of counting. , 2001, Current opinion in genetics & development.

[39]  P. Chiao,et al.  Identification of an Autoregulatory Feedback Pathway Involving Interleukin-1α in Induction of Constitutive NF-κB Activation in Pancreatic Cancer Cells* , 2004, Journal of Biological Chemistry.

[40]  R. Thweatt,et al.  Characterization Of IGFBP-3, PAI-1 and SPARC mRNA expression in senescent fibroblasts , 1996, Mechanisms of Ageing and Development.

[41]  Manuel Serrano,et al.  The common biology of cancer and ageing , 2007, Nature.

[42]  H. Harris,et al.  Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. , 2003, Arthritis and rheumatism.

[43]  L. Hayflick THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.

[44]  M. Ikeda,et al.  Reduction of nitric oxide producing activity associated with in vitro aging in cultured human umbilical vein endothelial cell. , 1993, Biochemical and biophysical research communications.

[45]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Li Fang,et al.  Inhibition of p21‐mediated ROS accumulation can rescue p21‐induced senescence , 2002, The EMBO journal.

[47]  I. Komuro,et al.  Angiotensin II Induces Premature Senescence of Vascular Smooth Muscle Cells and Accelerates the Development of Atherosclerosis via a p 21-Dependent Pathway , 2006 .

[48]  U. Andersson,et al.  RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages , 2005, Scandinavian journal of immunology.

[49]  D. Schadendorf,et al.  IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. , 1993, Journal of immunology.

[50]  E. Block,et al.  Senescence-enhanced oxidative stress is associated with deficiency of mitochondrial cytochrome c oxidase in vascular endothelial cells , 2003, Mechanisms of Ageing and Development.

[51]  R. Derynck,et al.  Effects of MGSA/GRO alpha on melanocyte transformation. , 1991, Oncogene.

[52]  I. Komuro,et al.  Angiotensin II Induces Premature Senescence of Vascular Smooth Muscle Cells and Accelerates the Development of Atherosclerosis via a p21-Dependent Pathway , 2006, Circulation.

[53]  D. Peeper,et al.  Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network , 2008, Cell.

[54]  J. Ward,et al.  Eotaxin (CCL11) Induces In Vivo Angiogenic Responses by Human CCR3+ Endothelial Cells1 , 2001, The Journal of Immunology.

[55]  Judith Campisi,et al.  Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.

[56]  T. Lüscher,et al.  Enhanced Peroxynitrite Formation Is Associated with Vascular Aging , 2000, The Journal of experimental medicine.

[57]  M. Barcellos-Hoff,et al.  Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. , 2000, Cancer research.

[58]  Š. Pospíšilová,et al.  High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops. , 2004, Biochemistry.

[59]  F. Orr,et al.  Tumor cell interactions with the microvasculature: a rate-limiting step in metastasis. , 2001, Surgical oncology clinics of North America.

[60]  A. J. Millis,et al.  Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. , 1992, Experimental cell research.

[61]  S. Brod Unregulated inflammation shortens human functional longevity , 2000, Inflammation Research.

[62]  M. Benson,et al.  Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia. , 2000, Urology.

[63]  G. Zeng,et al.  Differential regulation of collagenase and stromelysin mRNA in late passage cultures of human fibroblasts. , 1996, Experimental cell research.

[64]  R. Weinberg,et al.  The signals and pathways activating cellular senescence. , 2005, The international journal of biochemistry & cell biology.

[65]  J. Campisi,et al.  Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation , 2004, Journal of Cell Science.

[66]  J. Wallace,et al.  Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. , 2002, Blood.

[67]  J. Campisi Cellular senescence as a tumor-suppressor mechanism. , 2001, Trends in cell biology.

[68]  W. Hornebeck,et al.  Proteolyzed matrix as a template for the regulation of tumor progression. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[69]  John M Sedivy,et al.  Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). , 2004, Molecular cell.

[70]  Gordon J. Lithgow,et al.  MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8 , 2009, Aging.

[71]  P. Nelson,et al.  The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. , 2006, Cancer research.

[72]  P. Rogalla,et al.  Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. , 2005, The American journal of pathology.

[73]  H. Lodish Molecular Cell Biology , 1986 .

[74]  Qin M. Chen,et al.  Novel mechanisms of sublethal oxidant toxicity: induction of premature senescence in human fibroblasts confers tumor promoter activity. , 2003, Experimental cell research.

[75]  J. R. Smith,et al.  Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. , 1989, Experimental cell research.

[76]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[77]  Alberto Mantovani,et al.  Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. , 2006, European journal of cancer.

[78]  D. Bar-Sagi,et al.  Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. , 2004, Cancer cell.

[79]  V. Ferrans,et al.  Ras Proteins Induce Senescence by Altering the Intracellular Levels of Reactive Oxygen Species* , 1999, The Journal of Biological Chemistry.

[80]  M. Bianchi,et al.  HMG proteins: dynamic players in gene regulation and differentiation. , 2005, Current opinion in genetics & development.

[81]  M. Bianchi,et al.  HMGB1 loves company , 2009, Journal of leukocyte biology.

[82]  C. Berking,et al.  Differential response of primary and metastatic melanomas to neutrophils attracted by IL‐8 , 2003, International journal of cancer.

[83]  Michael R. Elliott,et al.  Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance , 2009, Nature.

[84]  Jeen-Woo Park,et al.  Expression of connective tissue growth factor, a biomarker in senescence of human diploid fibroblasts, is up-regulated by a transforming growth factor-beta-mediated signaling pathway. , 2004, Biochemical and biophysical research communications.

[85]  A. Ben-Baruch Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. , 2006, Seminars in cancer biology.

[86]  A. Ridley,et al.  Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. , 1998, Molecular biology of the cell.

[87]  B. Foster,et al.  Pharmacological rescue of mutant p53 conformation and function. , 1999, Science.

[88]  Robert S. Balaban,et al.  Mitochondria, Oxidants, and Aging , 2005, Cell.

[89]  M. Burdick,et al.  Cancer CXC chemokine networks and tumour angiogenesis. , 2006, European journal of cancer.

[90]  I. Roninson,et al.  Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[91]  J. Yates,et al.  PRAK Is Essential for ras-Induced Senescence and Tumor Suppression , 2007, Cell.

[92]  T. Jacks,et al.  Restoration of p53 function leads to tumour regression in vivo , 2007, Nature.

[93]  K. Chin,et al.  A Human-Like Senescence-Associated Secretory Phenotype Is Conserved in Mouse Cells Dependent on Physiological Oxygen , 2010, PloS one.

[94]  D. Ribatti,et al.  I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. , 2000, Blood.

[95]  H. Rauvala,et al.  Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). , 2007, Journal of leukocyte biology.

[96]  M. Herlyn,et al.  Low-Level Monocyte Chemoattractant Protein-1 Stimulation of Monocytes Leads to Tumor Formation in Nontumorigenic Melanoma Cells1 , 2001, The Journal of Immunology.

[97]  J. McLachlan,et al.  Immunological functions of aged human monocytes. , 1995, Pathobiology : journal of immunopathology, molecular and cellular biology.

[98]  P. Carmeliet,et al.  uPAR: a versatile signalling orchestrator , 2002, Nature Reviews Molecular Cell Biology.

[99]  J. Little,et al.  Cellular mechanisms for low-dose ionizing radiation-induced perturbation of the breast tissue microenvironment. , 2005, Cancer research.

[100]  F. D. D. Fagagna Living on a break: cellular senescence as a DNA-damage response , 2008, Nature Reviews Cancer.

[101]  Jessie C. Jeyapalan,et al.  Accumulation of senescent cells in mitotic tissue of aging primates , 2007, Mechanisms of Ageing and Development.

[102]  Frederick W. Alt,et al.  DNA Repair, Genome Stability, and Aging , 2005, Cell.

[103]  P. Adams Remodeling chromatin for senescence , 2007, Aging cell.

[104]  S. Bode-Böger,et al.  Asymmetric dimethylarginine (ADMA) accelerates cell senescence , 2005, Vascular medicine.

[105]  C. Franceschi,et al.  Aging, Longevity, Inflammation, and Cancer , 2004, Annals of the New York Academy of Sciences.

[106]  C. Schmitt Senescence, apoptosis and therapy — cutting the lifelines of cancer , 2003, Nature Reviews Cancer.

[107]  N. Carter,et al.  A DNA damage checkpoint response in telomere-initiated senescence , 2003, Nature.

[108]  Shu-Chun Lin,et al.  Ripe areca nut extract induces G1 phase arrests and senescence-associated phenotypes in normal human oral keratinocyte. , 2006, Carcinogenesis.

[109]  K. Wiman,et al.  Reactivation of mutant p53: molecular mechanisms and therapeutic potential , 2007, Oncogene.

[110]  J. Campisi,et al.  The senescence-associated secretory phenotype: the dark side of tumor suppression. , 2010, Annual review of pathology.

[111]  M. Barbacid,et al.  Tumour biology: Senescence in premalignant tumours , 2005, Nature.

[112]  J. Campisi,et al.  Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[113]  Kimi Yamakoshi,et al.  The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression. , 2004, The journal of medical investigation : JMI.

[114]  J. Campisi,et al.  Cellular senescence: when bad things happen to good cells , 2007, Nature Reviews Molecular Cell Biology.

[115]  C. Prives,et al.  High mobility group protein-1 (HMG-1) is a unique activator of p53. , 1998, Genes & development.

[116]  J. Campisi Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors , 2005, Cell.

[117]  S. Plymate,et al.  Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium. , 2000, Endocrinology.

[118]  A. Frey Myeloid suppressor cells regulate the adaptive immune response to cancer. , 2006, The Journal of clinical investigation.

[119]  Carlos Cordon-Cardo,et al.  Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas , 2007, Nature.

[120]  Edward G Lakatta,et al.  Arterial aging: is it an immutable cardiovascular risk factor? , 2005, Hypertension.

[121]  K. Chien,et al.  Longevity and Lineages: Toward the Integrative Biology of Degenerative Diseases in Heart, Muscle, and Bone , 2005, Cell.

[122]  G. Peters,et al.  Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all , 2006, Nature Reviews Molecular Cell Biology.

[123]  T. Kislinger,et al.  Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases , 2000, Nature.

[124]  P. Chène Inhibiting the p53–MDM2 interaction: an important target for cancer therapy , 2003, Nature Reviews Cancer.

[125]  F. Ishikawa,et al.  Cellular senescence and chromatin structure , 2007, Chromosoma.

[126]  H. Katinger,et al.  Subtractive Hybridization of mRNA from early passage and senescent endothelial cells , 2000, Experimental Gerontology.

[127]  A. Mantovani,et al.  Chemokines in neoplastic progression. , 2004, Seminars in cancer biology.

[128]  Feng Yang,et al.  Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. , 2005, Cancer research.

[129]  J. Campisi,et al.  A Role for Fibroblasts in Mediating the Effects of Tobacco-Induced Epithelial Cell Growth and Invasion , 2008, Molecular Cancer Research.

[130]  S. Brown,et al.  Post-transcriptional regulation of interleukin 1 alpha in various strains of young and senescent human umbilical vein endothelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[131]  D. Palmieri,et al.  Age-related expression of PEDF/EPC-1 in human endometrial stromal fibroblasts: implications for interactive senescence. , 1999, Experimental cell research.

[132]  B. Groner,et al.  Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain , 1997, Nature Medicine.

[133]  C. J. Collins,et al.  Involvement of the INK4a/Arf gene locus in senescence , 2003, Aging cell.

[134]  Mitch Leslie,et al.  The age of cancer. , 2006, Science of aging knowledge environment : SAGE KE.

[135]  S. Lowe,et al.  Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence , 2003, Cell.

[136]  M. Serrano,et al.  Senescence in tumours: evidence from mice and humans , 2010, Nature Reviews Cancer.

[137]  Motowo Nakajima,et al.  Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[138]  R. Weinberg,et al.  When cells get stressed: an integrative view of cellular senescence. , 2004, The Journal of clinical investigation.

[139]  J. Shay,et al.  BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.

[140]  J. Shay,et al.  Hallmarks of senescence in carcinogenesis and cancer therapy , 2004, Oncogene.

[141]  K. Tracey,et al.  Activation of gene expression in human neutrophils by high mobility group box 1 protein. , 2003, American journal of physiology. Cell physiology.

[142]  Patricia D. Castro,et al.  Cellular senescence in the pathogenesis of benign prostatic hyperplasia , 2003, The Prostate.

[143]  B. Vandenbunder,et al.  Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway , 2002, Oncogene.

[144]  J. Thiery Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[145]  P. Fisher,et al.  Human Polynucleotide Phosphorylase (hPNPaseold-35) , 2004, Cancer Research.

[146]  P. Dhawan,et al.  Role of CXCL1 in tumorigenesis of melanoma , 2002, Journal of leukocyte biology.